Clinical Trials | November 29, 2023
Roche expands hepatitis diagnostics portfolio
Almost 300 million people globally have chronic hepatitis B
Almost 300 million people globally have chronic hepatitis B
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC)
Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite
The data highlight the three drug candidates' potential for clinical development and promising synergistic utilities in new indications
The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care
The requirement of blood in India is estimated to be 8.5 million to 10 million units/per year, whereas the available supply is only 7.4 million units/per year
UNICEF award is worth US $98.755 million for supply of around 99.70 million doses during calendar years 2023-2027
The ANDA was filed as 'First to File' submission on NCE-1 date.
Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
She joins Enveda from Gilead Sciences
Subscribe To Our Newsletter & Stay Updated
